Axsome Therapeutics Inc (AXSM)
75.75
-1.22
(-1.59%)
USD |
NASDAQ |
May 08, 16:00
75.75
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Gross Profit Margin (Quarterly): 91.60% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 91.60% |
| December 31, 2023 | 89.69% |
| September 30, 2023 | 88.70% |
| June 30, 2023 | 90.15% |
| Date | Value |
|---|---|
| March 31, 2023 | 92.01% |
| December 31, 2022 | 90.60% |
| September 30, 2022 | 88.58% |
| June 30, 2022 | 88.85% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
88.58%
Minimum
Sep 2022
92.01%
Maximum
Mar 2023
90.02%
Average
89.92%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Krystal Biotech Inc | 94.65% |
| Amgen Inc | 57.03% |
| Vertex Pharmaceuticals Inc | 87.27% |
| Alnylam Pharmaceuticals Inc | 86.65% |
| Catalyst Pharmaceuticals Inc | 85.70% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -148.9% |
| Return on Assets | -54.17% |
| Return on Invested Capital | -79.94% |
| Profit Margin (Quarterly) | -91.14% |
| Operating Margin (Quarterly) | -91.58% |
| Return on Net Operating Assets | -183.1% |